The role of serum brain injury biomarkers in individuals with a mild-to-moderate COVID infection and Long-COVID - results from the prospective population-based COVI-GAPP study

Julia Telser, Kirsten Grossmann, Ornella C Weideli, Dorothea Hillmann, Stefanie Aeschbacher, Niklas Wohlwend, Laura Velez, Jens Kuhle, Aleksandra Maleska, Pascal Benkert, Corina Risch, David Conen, Martin Risch, Lorenz Risch
doi: https://doi.org/10.1101/2023.02.15.23285972

Article usage

Article usage: February 2023 to July 2025

AbstractFullPdf
Feb 20234059163
Mar 2023171041
Apr 202345719
May 202327210
Jun 20232554
Jul 20231613
Aug 202331129
Sep 20232065
Oct 20231584
Nov 20232335
Dec 20231234
Jan 20241021
Feb 20241534
Mar 2024427
Apr 20241322
May 20241425
Jun 202418510
Jul 202417310
Aug 202411410
Sep 20242066
Oct 20241335
Nov 20242409
Dec 20242518
Jan 20251145
Feb 2025262423
Mar 2025322010
Apr 202526113
May 20251548
Jun 202517911
Jul 20251597
Back to top
Posted February 16, 2023.
Download PDF
Data/Code
Email
The role of serum brain injury biomarkers in individuals with a mild-to-moderate COVID infection and Long-COVID - results from the prospective population-based COVI-GAPP study
Julia Telser, Kirsten Grossmann, Ornella C Weideli, Dorothea Hillmann, Stefanie Aeschbacher, Niklas Wohlwend, Laura Velez, Jens Kuhle, Aleksandra Maleska, Pascal Benkert, Corina Risch, David Conen, Martin Risch, Lorenz Risch
medRxiv 2023.02.15.23285972; doi: https://doi.org/10.1101/2023.02.15.23285972
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area